AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-84
Results: 26-50/84

Authors: LAZARUS HM GALE RP
Citation: Hm. Lazarus et Rp. Gale, BLOOD-CELL AND BONE-MARROW TRANSPLANTS, Bone marrow transplantation, 18(5), 1996, pp. 839-841

Authors: SPIRO TP ODAY DG BARDENSTEIN D COOPER BW LAZARUS HM
Citation: Tp. Spiro et al., SEVERE ACUTE GRAFT-VERSUS-HOST DISEASE OF CONJUNCTIVAE AFTER ALLOGENEIC BLOOD PROGENITOR-CELL INFUSION, Bone marrow transplantation, 17(6), 1996, pp. 1179-1180

Authors: IQBAL M CREGER RJ FOX RM COOPER BW JACOBS G STELLATO TA LAZARUS HM
Citation: M. Iqbal et al., LAPAROSCOPIC LIVER-BIOPSY TO EVALUATE HEPATIC-DYSFUNCTION IN PATIENTSWITH HEMATOLOGIC MALIGNANCIES - A USEFUL TOOL TO EFFECT CHANGES IN MANAGEMENT, Bone marrow transplantation, 17(4), 1996, pp. 655-662

Authors: LAZARUS HM ELIAS AD
Citation: Hm. Lazarus et Ad. Elias, AUTOLOGOUS BONE-MARROW AND PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTS IN SMALL-CELL LUNG-CANCER, Bone marrow transplantation, 17(1), 1996, pp. 1-3

Authors: TAHSILDAR HI REMLER BF CREGER RJ COOPER BW SNODGRASS SM TARR RW LAZARUS HM
Citation: Hi. Tahsildar et al., DELAYED, TRANSIENT ENCEPHALOPATHY AFTER MARROW TRANSPLANTATION - CASE-REPORTS AND MRI FINDINGS IN 4 PATIENTS, Journal of neuro-oncology, 27(3), 1996, pp. 241-250

Authors: KAUR S COOPER G FAKULT S LAZARUS HM
Citation: S. Kaur et al., INCIDENCE AND OUTCOME OF OVERT GASTROINTESTINAL-BLEEDING IN PATIENTS UNDERGOING BONE-MARROW TRANSPLANTATION, Digestive diseases and sciences, 41(3), 1996, pp. 598-603

Authors: ESPINOSA MTF FOX R CREGER RJ LAZARUS HM
Citation: Mtf. Espinosa et al., MICROBIOLOGIC CONTAMINATION OF PERIPHERAL-BLOOD PROGENITOR CELLS COLLECTED FOR HEMATOPOIETIC-CELL TRANSPLANTATION, Transfusion, 36(9), 1996, pp. 789-793

Authors: SCHENKEIN DP ROITMAN D MILLER KB MORELLI J STADTMAUER E PECORA AL CASSILETH P LAZARUS HM
Citation: Dp. Schenkein et al., A PHASE-II TRIAL OF FILGRASTIM (G-CSF) SUPPORTED HIGH-DOSE SEQUENTIALCHEMOTHERAPY AND PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTATION ASINITIAL THERAPY FOR HIGH-RISK NON-HODGKINS LYMPHOMA(NHL) - A MULTICENTER PILOT-STUDY, Blood, 88(10), 1996, pp. 462-462

Authors: MOSS TJ COOPER B KENNEDY MJ MEAGHER R PECORA AL HERZIG RM UMIEL T COPELAN E AKARD L JANSEN J CARRUM G LAZARUS HM
Citation: Tj. Moss et al., THE PROGNOSTIC VALUE OF IMMUNOCYTOCHEMICAL (ICC) ANALYSIS ON BONE-MARROW (BM) TAKEN FROM PATIENTS WITH STAGE IV BREAST-CANCER UNDERGOING AUTOLOGOUS TRANSPLANT (ABMT) THERAPY, Blood, 88(10), 1996, pp. 500-500

Authors: LAYTON TJ OSTRANDER AB SHEA T LAZARUS HM BROWN R DIPERSIO J ROSS AA
Citation: Tj. Layton et al., USE OF NESTED PCR FOR DETECTION OF T(14-18)-POSITIVE CELLS FOLLOWING CD34-HODGKINS-LYMPHOMA PATIENTS( SELECTION IN SAMPLES FROM NON), Blood, 88(10), 1996, pp. 1499-1499

Authors: LAZARUS HM
Citation: Hm. Lazarus, AN ALTERNATIVE TECHNIQUE TO CREATE THE PNEUMOPERITONEUM FOR LAPAROSCOPIC SURGERY, Surgical laparoscopy & endoscopy, 5(3), 1995, pp. 205-208

Authors: LAZARUS HM
Citation: Hm. Lazarus, BONE-MARROW TRANSPLANTATION IN LOW-GRADE NON-HODGKINS-LYMPHOMA, Leukemia & lymphoma, 17(3-4), 1995, pp. 199-210

Authors: LAZARUS HM CRUIKSHANK WW NARASIMHAN N KAGAN HM CENTER DM
Citation: Hm. Lazarus et al., INDUCTION OF HUMAN MONOCYTE MOTILITY BY LYSYL OXIDASE, Matrix biology, 14(9), 1995, pp. 727-731

Authors: KUTTAH L WEBER F CREGER RJ FOX RM COOPER BW JACOBS G LAZARUS HM
Citation: L. Kuttah et al., ACUTE CHOLECYSTITIS AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA, Annals of oncology, 6(3), 1995, pp. 302-304

Authors: GORDON LI BROWN SG TALLMAN MS RADEMAKER AW WEITZMAN SA LAZARUS HM KELLEY CH MANGAN C RUBIN H FOX RM CREGER RJ WINTER JN
Citation: Li. Gordon et al., SEQUENTIAL-CHANGES IN SERUM IRON AND FERRITIN IN PATIENTS UNDERGOING HIGH-DOSE CHEMOTHERAPY AND RADIATION WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION - POSSIBLE IMPLICATIONS FOR TREATMENT RELATED TOXICITY, Free radical biology & medicine, 18(3), 1995, pp. 383-389

Authors: FIELDS KK ELFENBEIN GJ LAZARUS HM COOPER BW PERKINS JB CREGER RJ BALLESTER OF HIEMENZ JH JANSSEN WE ZORSKY PE
Citation: Kk. Fields et al., MAXIMUM-TOLERATED DOSES OF IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE GIVEN OVER 6 DAYS FOLLOWED BY AUTOLOGOUS STEM-CELL RESCUE - TOXICITY PROFILE, Journal of clinical oncology, 13(2), 1995, pp. 323-332

Authors: LAWRENCE JB YOMTOVIAN RA DILLMAN C MASARIK SR CHONGKOLWATANA V CREGER RJ MANKA A HAMMONS T LAZARUS HM
Citation: Jb. Lawrence et al., RELIABILITY OF AUTOMATED PLATELET COUNTS - COMPARISON WITH MANUAL METHOD AND UTILITY FOR PREDICTION OF CLINICAL BLEEDING, American journal of hematology, 48(4), 1995, pp. 244-250

Authors: LAZARUS HM ROWE JM
Citation: Hm. Lazarus et Jm. Rowe, NEW AND EXPERIMENTAL THERAPIES FOR TREATING GRAFT-VERSUS-HOST DISEASE, Blood reviews, 9(2), 1995, pp. 117-133

Authors: LAZARUS HM HAYNESWORTH SE GERSON SL ROSENTHAL NS CAPLAN AI
Citation: Hm. Lazarus et al., EX-VIVO EXPANSION AND SUBSEQUENT INFUSION OF HUMAN BONE-MARROW-DERIVED STROMAL PROGENITOR CELLS (MESENCHYMAL PROGENITOR CELLS) - IMPLICATIONS FOR THERAPEUTIC USE, Bone marrow transplantation, 16(4), 1995, pp. 557-564

Authors: LAZARUS HM WINTON EF WILLIAMS SF GRINBLATT D CAMPION M COOPER BW GUNN H MANFREDA S ISAACS RE
Citation: Hm. Lazarus et al., PHASE-I MULTICENTER TRIAL OF INTERLEUKIN-6 THERAPY AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ADVANCED BREAST-CANCER, Bone marrow transplantation, 15(6), 1995, pp. 935-942

Authors: PRINCE GM NGUYEN M LAZARUS HM BRODSKY RA TERSTAPPEN LWMM MEDOF ME
Citation: Gm. Prince et al., PERIPHERAL-BLOOD HARVEST OF UNAFFECTED CD34(-) HEMATOPOIETIC PRECURSORS IN PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA() CD38(), Blood, 86(9), 1995, pp. 3381-3386

Authors: KOC ON GERSON SL FOX RM SCHUPP JE MARKO DA STECKLEY JA LAZARUS HM
Citation: On. Koc et al., INFUSION OF CD34 ENRICHED PERIPHERAL-BLOOD PROGENITOR CELLS RESULT INRAPID ENGRAFTMENT AFTER HIGH-DOSE CHEMOTHERAPY IN PATIENTS WITH ADVANCED LYMPHOMA, Blood, 86(10), 1995, pp. 917-917

Authors: WINTER IN LAZARUS HM RADEMAKER AF BAUMAN A COOPER B THOMAS R GORDON LI TALLMAN MS RUBIN H GERSON S MILLER LL
Citation: In. Winter et al., COMPARISON OF PIXY321 AND GM-CSF FOR MOBILIZATION OF PERIPHERAL-BLOODPROGENITOR CELLS (PBPC) IN ADVANCED BREAST-CANCER, Blood, 86(10), 1995, pp. 2301-2301

Authors: ROWLINGS PA ANTMAN KS HOROWITZ MM WILLIAMS SF LAZARUS HM FIELDS KK PELZ C SOBOCINSKI KA ARMITAGE JO
Citation: Pa. Rowlings et al., PROGNOSTIC FACTORS IN AUTOTRANSPLANTS FOR METASTATIC BREAST-CANCER, Blood, 86(10), 1995, pp. 2459-2459

Authors: SCHENKEIN DP MILLER KB SWEET M ROSENBACH M STADTMAUER E CASSILETH P COOPER B LAZARUS HM
Citation: Dp. Schenkein et al., A PHASE-II TRIAL OF FILGRASTIM (G-CSF) SUPPORTED HIGH-DOSE SEQUENTIALCHEMOTHERAPY AND PERIPHERAL BOOD STEM-CELL (PBSC) TRANSPLANTATION AS INITIAL THERAPY FOR HIGH-RISK NON-HODSKINS LYMPHOMA(NHL) - A MULTICENTER PILOT-STUDY, Blood, 86(10), 1995, pp. 3844-3844
Risultati: 1-25 | 26-50 | 51-75 | 76-84